Parkinson's disease research clinic

About the clinic

The ForeFront Parkinson’s Disease clinic is a research-based facility that strives to develop better patient care and family support for people living with Parkinson’s Disease and related disorders. Our research investigates the causes underlying many of the problems faced by people living with these conditions. We hope a better understanding of these symptoms will improve quality of life. In addition, we have specific studies addressing novel treatment and diagnostic approaches.

Our Services

Get involved – discuss your health with medical leaders

Your participation in our research trials is crucial as our studies rely on people living with Parkinson’s Disease and related conditions. It’s also an opportunity to discuss your health with some of the best and brightest research leaders.

For patients needing clinical services, please click here

Participate in our research

We are currently running studies in freezing of gait, hallucinations and predicting disease, as well as clinical trials targeting specific symptoms and disease progression. Be part of history in the making – contact us to learn about participating in our work.

Our research program is always evolving so please contact us to find out more about our research.

Currently active clinical trials

Australian Parkinson's Mission Clinical Trials

Study using re-purposed medication to treat Parkinson's disease is now open to recruitment. This involves six visits over 62 weeks. For more information, please visit the Research Studies page.

Australian Parkinson’s Mission Clinical Trials: A study using re-purposed medication to treat Parkinson's disease is now open to recruitment. This involves six visits over 62 weeks. For more information, please visit the research page here.

TEMPO-2 Clinical Trial

TEMPO-2 Clinical Trial: A study trialling the efficacy, safety, and tolerability of a flexible dose investigational product on early Parkinson’s Disease is now open to recruitment. This involves 13 visits over approximately 35 weeks. Please contact stacey.west@sydney.edu.au for more information.

CLIN011 Clinical Trial

A study testing the effects of an investigational product on four different populations of people with neurodegenerative conditions. This involves 9 visits over approximately 12 weeks where participants will receive both active and inactive treatments.

This study is now open to recruitment for people who have a diagnosis of one of the following: Parkinson’s Disease, Parkinson’s Disease Dementia, Dementia with Lewy Bodies, or Mild Cognitive Impairment. Please contact stacey.west@sydney.edu.au for more information.

News_